{"id":"W4366004431","doi":"","title":"Spotlight on pembrolizumab in the treatment of advanced melanoma","year":2015,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Melanoma; Internal medicine; Cancer research; Immunotherapy; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002780255,0.0004516597,0.00101218,0.0009025567,0.0004500723,0.001587062,0.0008305839,0.003060752,0.00617091],"category_scores_gemma":[0.002286688,0.0002429352,0.0005642333,0.0008579305,0.0008723036,0.002659735,0.0005912889,0.004688489,0.002112272],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001013134,"about_ca_system_score_gemma":0.001534314,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001001496,"about_ca_topic_score_gemma":0.003896978,"domain_scores_codex":[0.9992054,0.0002243801,0.00009838932,0.00007957361,0.0002943837,0.00009792137],"domain_scores_gemma":[0.99794,0.0008963241,0.0001873701,0.00003270457,0.0006146631,0.0003289414],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008736729,0.0001700493,0.0004144405,0.002864237,0.00006020753,0.000378433,0.00008396491,0.0002971714,0.002775953,0.005965804,0.28796,0.698156],"study_design_scores_gemma":[0.0002828793,0.0008160286,0.00195391,0.002233509,0.00008398002,0.0008028201,0.0001463997,0.0004532035,0.0005519354,0.003823385,0.9888229,0.00002891861],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001956525,0.880469,0.0004387553,0.09435739,0.01558764,0.00003137684,0.0001108561,0.00006782099,0.006980506],"genre_scores_gemma":[0.01794657,0.8712729,0.001427273,0.04847716,0.05150223,0.00005291571,0.0001715125,0.00004741217,0.009102104],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00617091,"threshold_uncertainty_score":0.02064371,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2558356997043778,"score_gpt":0.5488155397325114,"score_spread":0.2929798400281336,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}